Influenza vaccine adjuvants: status and progress
10.3760/cma.j.cn112309-20191231-00443
- VernacularTitle:流感疫苗佐剂现状及发展
- Author:
Xuanxuan NIAN
1
;
Jiayou ZHANG
;
Xiaoming YANG
Author Information
1. 武汉生物制品研究所有限责任公司病毒性疫苗研究二室，国家联合疫苗工程技术研究中心，武汉 430207
- From:
Chinese Journal of Microbiology and Immunology
2020;40(5):399-404
- CountryChina
- Language:Chinese
-
Abstract:
Currently, influenza vaccination is the most effective measure to control the epidemic of influenza. The addition of adjuvant in a vaccine can reduce the dose of antigen required, enhance the immunogenicity, and produce cross-protection. This review summarized the literature on influenza-related adjuvants and outlined the mechanism and safety of vaccine adjuvants approved and under development in order to provide reference for the development of new influenza vaccines.
